Scribe Therapeutics (NASDAQ:SCTX) Major Shareholder Bio Fund Ii L.P. Ah Acquires 333,333 Shares of Stock

Scribe Therapeutics Inc. (NASDAQ:SCTX) major shareholder Bio Fund Ii L.P. Ah purchased 333,333 shares of the business’s stock in a transaction dated Monday, July 27th. The shares were purchased at an average cost of $15.00 per share, with a total value of $4,999,995.00. Following the completion of the purchase, the insider directly owned 2,385,075 shares in the company, valued at approximately $35,776,125. This represents a 16.25% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Scribe Therapeutics Price Performance

Shares of NASDAQ SCTX traded up $0.30 during trading hours on Wednesday, hitting $18.36. The stock had a trading volume of 325,049 shares, compared to its average volume of 390,915. Scribe Therapeutics Inc. has a 52 week low of $17.31 and a 52 week high of $25.49.